1. Home
  2. RYAM vs MRVI Comparison

RYAM vs MRVI Comparison

Compare RYAM & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rayonier Advanced Materials Inc.

RYAM

Rayonier Advanced Materials Inc.

HOLD

Current Price

$5.84

Market Cap

422.1M

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.30

Market Cap

449.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYAM
MRVI
Founded
1926
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
422.1M
449.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
RYAM
MRVI
Price
$5.84
$3.30
Analyst Decision
Buy
Buy
Analyst Count
1
7
Target Price
$6.00
$4.57
AVG Volume (30 Days)
544.0K
1.2M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,471,356,000.00
$192,435,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.99
$9.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.35
$1.67
52 Week High
$8.56
$6.21

Technical Indicators

Market Signals
Indicator
RYAM
MRVI
Relative Strength Index (RSI) 41.16 43.08
Support Level $5.59 $3.44
Resistance Level $5.92 $3.59
Average True Range (ATR) 0.22 0.18
MACD -0.02 -0.05
Stochastic Oscillator 27.93 7.14

Price Performance

Historical Comparison
RYAM
MRVI

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: